Picture of Zura Bio logo

ZURA — Zura Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Zura Bio Ltd expected to post a loss of 25 cents a share - Earnings Preview

* Zura Bio Ltd  ZURA.OQ   ZURA.O  is expected to report
results on
August 14 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Zura Bio Ltd is for
a
loss of 25 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Strong Buy".​
    * Wall Street's median 12-month price target for Zura Bio
Ltd is
$17​, above​ its last closing price of $6.84. ​​​

This summary was machine generated August 12 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Zura Bio

See all news